| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |